Innoveren Scientific Inc.
IVRN
$0.0002
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 3.06% | -2.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.06% | -2.83% | |||
| Operating Income | -3.06% | 2.83% | |||
| Income Before Tax | -160.43% | 139.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -160.43% | 139.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -160.43% | 139.25% | |||
| EBIT | -3.06% | 2.83% | |||
| EBITDA | -3.05% | 2.84% | |||
| EPS Basic | -155.91% | 138.49% | |||
| Normalized Basic EPS | 2.85% | 16.51% | |||
| EPS Diluted | -194.38% | 122.80% | |||
| Normalized Diluted EPS | -64.72% | 50.75% | |||
| Average Basic Shares Outstanding | 8.08% | 1.99% | |||
| Average Diluted Shares Outstanding | -36.24% | 72.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||